Latest Breaking News On - Sun pharma to acquire concert pharmaceuticals - Page 1 : vimarsana.com

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun .

Sun pharmaSun pharma to acquire concert pharmaceuticalsAcquire concert pharmaceuticalsPotential treatmentAlopecia areataAdds deuruxolitinibPotential best in class oralGlobal infrastructureProvide broad accessAlopeciaareata strengthens sun pharmaGlobal dermatology franchiseLate stage productSignificant unmet need sun pharmaCommence tender offerAcquire all outstanding sharesCommon stock